Comprehensive Review on the Clinical Impact of Next-Generation Sequencing Tests for the Management of Advanced Cancer.
JCO Precis Oncol
; 7: e2200715, 2023 06.
Article
em En
| MEDLINE
| ID: mdl-37285561
ABSTRACT
PURPOSE:
This review summarizes the published evidence on the clinical impact of using next-generation sequencing (NGS) tests to guide management of patients with cancer in the United States.METHODS:
We performed a comprehensive literature review to identify recent English language publications that presented progression-free survival (PFS) and overall survival (OS) of patients with advanced cancer receiving NGS testing.RESULTS:
Among 6,475 publications identified, 31 evaluated PFS and OS among subgroups of patients who received NGS-informed cancer management. PFS and OS were significantly longer among patients who were matched to targeted treatment in 11 and 16 publications across tumor types, respectively.CONCLUSION:
Our review indicates that NGS-informed treatment can have an impact on survival across tumor types.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias
País/Região como assunto:
America do norte
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Canadá